Key regions: Brazil, India, Australia, United States, United Kingdom
The Antiviral Drugs market in Greece has been steadily growing over the years due to various factors.
Customer preferences: Customers in Greece have been increasingly demanding antiviral drugs due to the rise of viral infections in the country. The demand for these drugs has also been driven by the aging population in the country, who are more susceptible to viral infections. Additionally, the COVID-19 pandemic has further increased the demand for antiviral drugs.
Trends in the market: One of the major trends in the Antiviral Drugs market in Greece is the increased use of generic drugs. This trend has been driven by the high cost of branded drugs and the need for cost-effective treatment options. Another trend is the increasing use of combination therapies, which are more effective in treating viral infections. The market is also witnessing the development of new antiviral drugs, which are more effective and have fewer side effects.
Local special circumstances: Greece has been facing economic challenges in recent years, which have impacted the healthcare sector. The government has been implementing austerity measures, which have led to a reduction in healthcare spending. However, the COVID-19 pandemic has led to an increase in healthcare spending, particularly in the area of antiviral drugs.
Underlying macroeconomic factors: The Greek economy has been recovering in recent years, with GDP growth averaging 2% in the past few years. The government has implemented structural reforms to improve the business environment and attract foreign investment. The healthcare sector has also been undergoing reforms to improve efficiency and reduce costs. These factors have contributed to the growth of the Antiviral Drugs market in Greece.In conclusion, the Antiviral Drugs market in Greece has been growing due to the increasing demand for these drugs, driven by the rise of viral infections, the aging population, and the COVID-19 pandemic. The market is witnessing trends such as the increased use of generic drugs, combination therapies, and the development of new antiviral drugs. The local special circumstances in Greece include economic challenges and healthcare reforms. However, the underlying macroeconomic factors, such as GDP growth and structural reforms, have contributed to the growth of the market.
Data coverage:
Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.Modeling approach / Market size:
Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.Forecasts:
In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.Additional notes:
Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.
Mon - Fri, 9am - 6pm (EST)
Mon - Fri, 9am - 5pm (SGT)
Mon - Fri, 10:00am - 6:00pm (JST)
Mon - Fri, 9:30am - 5pm (GMT)
Mon - Fri, 9am - 6pm (EST)
